By lowering intracellular ROS and inhibiting NF-κB-dependent transcriptional priming of NLRP3, Nrf2 activity functionally lowers inflammasome formation in sterile neuroinflammatory conditions such as PD. Here, NLRP3 is linked to Parkinson disease.